About NuVasive
NuVasive is a Healthcare company based in San Diego (United States) founded in 1997, and was acquired by Globus Medical in February 2023. Smart surgical devices for spinal surgery are developed. NuVasive has raised $54.1 million across 5 funding rounds from investors including Kleiner Perkins, Globus Medical and Johnson & Johnson Innovation β JJDC. NuVasive has completed 7 acquisitions, including Biotronic, Ellipse Technologies and Globus Medical. Its website nuvasive.com draws about 123 thousand monthly visits. NuVasive offers products and services including XLIF, C360, P360, and Pulse. Its focus areas include Life Sciences, Orthopedics, Medical Devices and Surgical Tools. Its competitors include Stryker, Ensoma and CARLSMED; 2 of its 3 listed competitors have raised funding.
Company details
NuVasive was founded in 1997 in San Diego, United States, as a developer of medical devices focused on spinal surgery. Operations include the marketing of seven products, such as the stem cell-based Osteocel, and the NVM5 system for intraoperative neuromonitoring. The company went public in 2012 and acquired Ellipse Technologies, an orthopedic device maker, in January 2016. Activities center on orthopedic innovations in the healthcare sector.
- Headquarters San Diego, United States
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website nuvasive.com/home-new
- Social LinkedIn X Facebook Instagram YouTube
- Acquired by Globus Medical (Feb 2023)
- Total Equity Funding$54.1M (USD)
in 5 rounds
- Latest Funding Round$400M (USD), Post-IPO
May 2020
- InvestorsKleiner Perkins
& 6 more
- Investments & AcquisitionsBiotronic
& 6 more
- Acquired byGlobus Medical
(Feb 2023)
Products & Services of NuVasive
NuVasive offers a comprehensive portfolio of products and services, including XLIF, C360, P360, and Pulse.
Minimally invasive lateral lumbar fusion technique
Integrated solutions for anterior and posterior procedures
Techniques for open and less-invasive posterior surgeries
Platform to enhance surgical workflows and outcomes
Apps and channels of NuVasive
its YouTube channel NuVasiveInc has 19.3K subscribers and 30 videos.
Videos from NuVasive
The most watched videos on NuVasive's YouTube channel, NuVasiveInc (19.3K subscribers). Click a video to play it here.
More on NuVasiveInc.
Funding Insights of NuVasive
NuVasive has successfully raised a total of $54.1M across 5 strategic funding rounds. The most recent funding activity was a Post-IPO round of $400 million completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $54.1M
- Total Rounds 5
- Last Round Post-IPO β $400M
- First Round $29.3M
(May 2001)
- Investors Count 6
All 5 funding rounds of NuVasive with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May 2020 | $400M | Post-IPO | β | β | β |
| Oct 2011 | $40.46M | Post-IPO | β | β | β |
| Jun 2003 | $9.8M | Series D | β | β | β |
| Aug 2002 | $15M | Series D | β | β | |
| May 2001 | $29.3M | Series C | β | β |
7 investors in total: 7 institutional.
Investors in NuVasive
NuVasive has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Kleiner Perkins, Globus Medical and Johnson & Johnson Innovation β JJDC.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm backed by Johnson & Johnson | jnjinnovation.com/jjdc | Cambridge, United States | ||
VC firm focusing on life science sector | pappas-capital.com | Durham, United States | ||
Venture capital firm investing in early-stage tech startups | 1972 | kleinerperkins.com | Menlo Park, United States | |
| epvc.com | ||||
Life science & tech focused VC firm investing in the US | domainvc.com | Princeton, United States | ||
Financial services are provided by William Blair to global clients. | williamblair.com | Chicago, United States | ||
Developer of minimally invasive products for musculoskeletal procedures | 2003 | globusmedical.com | Audubon, United States |
Investor details for NuVasive
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of NuVasive
468 people are tracked at NuVasive (127 in leadership, 10 in board & advisors, 331 in team).
| Name | Role | Group |
|---|---|---|
Yeqing Cao | Director, Product Development | Leadership |
Dan Cummings | Zone Director - East | Leadership |
Mark Fromhold | Director, Product Development | Leadership |
Craig Blinman | Director, Operations APAC | Leadership |
John J. Mulcahy | Chief Commercial Officer, President Of Orthopedics | Leadership |
Mark Etheridge | Area Sales Director | Leadership |
Jeremy Tuten | Vice President Of Sales | Leadership |
Lisandra Abreu-Kelsey | Senior Talent Acquisition Partner - EMEA | Leadership |
Alessio Lentati | Country Sales Director | Leadership |
Jordan Smith | Southeast Area Director - Trauma | Leadership |
Suzanne Dinatale | Vice President Of Biologics-west | Leadership |
Larry Brickman | Area Director/sales Manager, NYC Empire Region | Leadership |
Andrew Fowler | Vice President Of US Sales - Pacific Zone | Leadership |
J.j. McIntyre | Area Director- Central US | Leadership |
Ryan Reynolds | Area Director | Leadership |
Jeff Blumenthal | Zone Vice President | Leadership |
Daniel Paul | Senior Vice President, Global Quality, Regulatory And Information Technology | Leadership |
Christy Mace | Director of Product Development | Leadership |
Keith Pfeil | President & CEO | Leadership |
Lynn Kennelly | Director Talent Acquisition | Leadership |
448 more people are available in the full profile.
Complete people profiles for NuVasive
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by NuVasive
NuVasive has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Biotronic, Ellipse Technologies and Globus Medical.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Globus Medical is engaged in developing innovative medical devices for spine and orthopedic solutions. | simplifymedical.com | Mountain View, United States | 2013 | Feb 2021 | $150M | |
Patient's nervous system is monitored during surgery by clinical specialists. | safepassagehealth.com | New York, United States | 2007 | Dec 2017 | β’β’β’β’ | |
Develops fusion devices using patented porous PEEK technology | verteraspine.com | Atlanta, United States | 2013 | Sep 2017 | β’β’β’β’ | |
Intraoperative neurophysiological monitoring services are provided to surgeons and facilities. | biotronic.com | Ann Arbor, United States | 1978 | Jun 2016 | $98M | |
Low-radiation fluoroscopic images are enhanced for better resolution and contrast. | lessray.com | Durham, United States | 2012 | Jun 2016 | β’β’β’β’ | |
Remote-controlled implants for spinal and orthopedic applications are provided. | ellipse-tech.com | Aliso Viejo, United States | 2005 | Jan 2016 | $410M | |
Intraoperative neurophysiological monitoring is conducted for spinal and brain surgeries. | impulsemonitoring.com | Columbia, United States | 2002 | Sep 2011 | $80M |
Complete acquisition details for NuVasive
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of NuVasive
12 dated milestones of NuVasive across 26 years, from founding to its latest funding, stage changes and deals.
- Founded NuVasive is founded.
- Funding First funding round of $29.3M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Impulse Monitoring.
- Acquisition Acquires Ellipse Technologies.
- Acquisition Acquires Lessray.
- Acquisition Acquires Biotronic.
- Acquisition Acquires Vertera Spine.
- Acquisition Acquires SafePassage Health.
- Funding Latest funding round, Post-IPO, of $400.0M.
- Acquisition Acquires Globus Medical.
- Exit Acquired by Globus Medical.
Competitors of NuVasive
NuVasive has 3 listed competitors in our database, 2 of them funded. They include Stryker, Ensoma and CARLSMED.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| stryker.com | 1941 | Kalamazoo, United States | 25,035 | 3D-printed orthopedic products are manufactured for medical applications. | ||
| ensoma.com | 2019 | Boston, United States | $205M | 52 | Provider of in vivo stem cell modification technologies and vector-based drug delivery tool | |
| carlsmed.com | 2018 | San Diego, United States | $109.63M | 59 | Developer of devices for spine surgery |
Detailed competitors of NuVasive
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of NuVasive
The website of NuVasive (nuvasive.com) receives about 122.8K visits a month.
- Monthly visits122.8K
Websites whose visitors overlap most with NuVasive. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| globusmedical.com | 100% | 77.8K | #437,693 | View details | |
| orthofix.com | 99% | 48.4K | #571,556 | View details | |
alphatecspine.com | alphatecspine.com | 98% | #3,976,987 | β | |
| k2m.com | 94% | View details | |||
zimmer.com | zimmer.com | 83% | #1,979,435 | β | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for NuVasive
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
3 companies that operate in the same segment as NuVasive (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Nuvasive
Complete news archive for NuVasive
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about NuVasive
NuVasive was founded in 1997 and raised its 1st funding round 4 years after it was founded.
NuVasive is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
NuVasive is a funded company, having raised a total of $54.1M across 5 funding rounds to date. The company's 1st funding round was a Series C of $29.3M, raised on May 2001.
NuVasive was founded in 1997 in San Diego, United States, as a developer of medical devices focused on spinal surgery. Operations include the marketing of seven products, such as the stem cell-based Osteocel, and the NVM5 system for intraoperative neuromonitoring. The company went public in 2012 and acquired Ellipse Technologies, an orthopedic device maker, in January 2016. Activities center on orthopedic innovations in the healthcare sector.
NuVasive offers XLIF, C360, P360, and Pulse.
NuVasive has made 7 acquisitions, including Biotronic, Ellipse Technologies, and Globus Medical.
NuVasive has 7 investors. Key investors include Kleiner Perkins, Globus Medical, Johnson & Johnson Innovation β JJDC, William Blair, and Pappas Capital.
Yes. NuVasive was acquired by Globus Medical in February 2023.
The website of NuVasive receives about 123 thousand visits a month.

